Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bristol-Myers Squibb Company 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 USA

P: 212-546-4000

Description:

Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.

Key Statistics

Overview:

Market Capitalization, $K 77,633,456
Shares Outstanding, K 1,635,766
Annual Sales, $ 22,561 M
Annual Net Income, $ 4,920 M
Last Quarter Sales, $ 6,273 M
Last Quarter Net Income, $ 1,432 M
60-Month Beta 0.73
% of Insider Shareholders 0.13%
% of Institutional Shareholders 80.11%
Float, K 1,633,640
% Float 99.87%

Growth:

1-Year Return -21.04%
3-Year Return -18.96%
5-Year Return -5.96%
5-Year Revenue Growth 37.69%
5-Year Earnings Growth 118.68%
5-Year Dividend Growth -9.09%

Per-Share Information:

Most Recent Earnings 1.18 on 07/25/19
Next Earnings Date N/A
Earnings Per Share ttm 4.31
EPS Growth vs. Prev Qtr 7.27%
EPS Growth vs. Prev Year 16.83%
Annual Dividend Rate, $ 1.64
Annual Dividend Yield 3.49%
Most Recent Dividend 0.410 on 07/03/19
Next Ex-Dividends Date 07/03/19
Dividend Payable Date 08/01/19
Dividend Payout Ratio 37.46
Most Recent Split 2-1 on 03/01/99

BMY Ratios

Ratio
Price/Earnings ttm 10.90
Price/Earnings forward 17.31
Price/Earnings to Growth 2.26
Return-on-Equity (After Tax) 47.63
Return-on-Assets (Before Tax) 17.81
Profit Margin % 21.81
Net Margin % 16.31
Debt/Equity 0.37
Price/Sales 3.41
Price/Cash Flow 10.72
Price/Book 4.63
Book Value/Share 9.87
Interest Coverage 15.44

BMY Dividends

Date Value
07/03/19 $0.4100
04/04/19 $0.4100
01/03/19 $0.4100
10/04/18 $0.4000
07/05/18 $0.4000
04/05/18 $0.4000
01/04/18 $0.4000
10/05/17 $0.3900
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar